Cargando…

Clinical and Patient-Reported Outcomes of Direct-Acting Antivirals for the Treatment of Chronic Hepatitis C Among Patients on Opioid Agonist Treatment: A Real-world Prospective Cohort Study

BACKGROUND: Patient-reported outcomes (PROs) can help to reduce uncertainties about hepatitis C virus (HCV) treatment with direct-acting antivirals (DAAs) among people who inject drugs and increase treatment uptake in this high-risk group. Besides clinical data, this study analyzed for the first tim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schulte, Bernd, Schmidt, Christiane S, Manthey, Jakob, Strada, Lisa, Christensen, Stefan, Cimander, Konrad, Görne, Herbert, Khaykin, Pavel, Scherbaum, Norbert, Walcher, Stefan, Mauss, Stefan, Schäfer, Ingo, Verthein, Uwe, Rehm, Jürgen, Reimer, Jens
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Major Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452367/ https://www.ncbi.nlm.nih.gov/pubmed/32875003 http://dx.doi.org/10.1093/ofid/ofaa317

Ejemplares similares

Factors associated with health-related quality of life in a large national sample of patients receiving opioid substitution treatment in Germany: A cross-sectional study
por: Strada, Lisa, et al.
Publicado: (2019)

Epidemiology of hepatitis C virus infection among people receiving opioid substitution therapy (ECHO): study protocol
por: Strada, Lisa, et al.
Publicado: (2015)

The potential effects of an extended alcohol withdrawal treatment programme on morbidity and mortality among inpatients in the German city of Bremen: a simulation study
por: Manthey, Jakob, et al.
Publicado: (2020)

Measuring quality of life in opioid-dependent people: a systematic review of assessment instruments
por: Strada, Lisa, et al.
Publicado: (2017)

Addiction Recovery Among Opioid-Dependent Patients Treated With Injectable Subcutaneous Depot Buprenorphine: Study Protocol of a Non-randomized Prospective Observational Study (ARIDE)
por: Schulte, Bernd, et al.
Publicado: (2020)

When higher doses in opioid replacement treatment are still inadequate – association to multidimensional illness severity: a cohort study
por: Reimer, Jens, et al.
Publicado: (2014)

Maintenance treatment for opioid dependence with slow-release oral morphine: a randomized cross-over, non-inferiority study versus methadone
por: Beck, Thilo, et al.
Publicado: (2014)

Optimizing Hepatitis C Virus (HCV) Treatment in a US Colocated HCV/Opioid Agonist Therapy Program
por: Habchi, Jackie, et al.
Publicado: (2020)

Opioid use disorder in Germany: healthcare costs of patients in opioid maintenance treatment
por: Reimer, Jens, et al.
Publicado: (2019)

1981. Real-World Data on Safety and Effectiveness of Glecaprevir/Pibrentasvir for the Treatment of Patients With Chronic Hepatitis C Virus Infection on Opioid Substitution Therapy: Latest Results from the German Hepatitis C-Registry
por: Reimer, Jens, et al.
Publicado: (2018)

Controlled administration of cannabis to mitigate cannabis-attributable harm among recreational users: a quasi-experimental study in Germany
por: Manthey, Jakob, et al.
Publicado: (2020)

Declines in Depressive Symptoms Among People who Inject Drugs Treated With Direct-Acting Antivirals While on Opioid Agonist Therapy
por: Pericot-Valverde, Irene, et al.
Publicado: (2020)

Alcohol and Cannabis Consumption Does Not Diminish Cure Rates in a Real-World Cohort of Chronic Hepatitis C Virus Infected Patients on Opioid Substitution Therapy—Data From the German Hepatitis C-Registry (DHC-R)
por: Christensen, Stefan, et al.
Publicado: (2019)

The opiate dosage adequacy scale for identification of the right methadone dose—a prospective cohort study
por: Walcher, Stephan, et al.
Publicado: (2016)

Novel Synthetic Opioids (NSO) Use in Opioid Dependents Entering Detoxification Treatment
por: Specka, Michael, et al.
Publicado: (2022)

Alcohol use in opioid agonist treatment
por: Nolan, Seonaid, et al.
Publicado: (2016)

Structural barriers in the context of opiate substitution treatment in Germany - a survey among physicians in primary care
por: Schulte, Bernd, et al.
Publicado: (2013)

Prevalence of Opioid Dependence and Opioid Agonist Treatment in the Berlin Custodial Setting: A Cross-Sectional Study
por: von Bernuth, Kira, et al.
Publicado: (2020)

Trends in risky prescriptions of opioid analgesics from 2011 to 2015 in Northern Germany
por: Verthein, Uwe, et al.
Publicado: (2020)

Interim opioid agonist treatment for opioid addiction: a systematic review
por: Samsó Jofra, Laura, et al.
Publicado: (2022)

Sofosbuvir-Based Direct-Acting Antiviral Therapies for HCV in People Receiving Opioid Substitution Therapy: An Analysis of Phase 3 Studies
por: Grebely, Jason, et al.
Publicado: (2018)

Suboptimal Uptake, Retention, and Adherence of Daily Oral Prexposure Prophylaxis Among People With Opioid Use Disorder Receiving Hepatitis C Virus Treatment
por: Brokus, Christopher, et al.
Publicado: (2021)

Availability of opioid agonist treatment and critical incidents in Forensic Clinics for Dependency Diseases in Germany
por: Reiners, Sven, et al.
Publicado: (2022)

HIV Testing Approaches to Optimize Prevention and Treatment for Key and Priority Populations in Malawi
por: Rucinski, Katherine, et al.
Publicado: (2022)

Evaluation of the Impact of HIV Serostatus on the Hepatitis C Virus Care Cascade and Injection Drug Use Among Persons Initiating Medication Treatment for Opioid Use Disorder
por: Lier, Audun J, et al.
Publicado: (2022)

Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes
por: Day, Nathaniel, et al.
Publicado: (2022)

Factors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: a literature review
por: Mravčík, Viktor, et al.
Publicado: (2013)

Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) Study
por: Larney, Sarah, et al.
Publicado: (2018)

Rescue Analgesia for Opioid-Dependent Individuals on Opioid Agonist Treatment during Hospitalization: Adherence to Guideline Treatment
por: Arnet, Isabelle, et al.
Publicado: (2023)

Engaging People Who Inject Drugs Living With HIV in Antiretroviral Treatment and Medication for Opioid Use Disorder: Extended Follow-up of HIV Prevention Trials Network (HPTN) 074
por: Lancaster, Kathryn E, et al.
Publicado: (2021)

Opioid agonist treatment (OAT) experiences and release plans among federally incarcerated individuals with opioid use disorder (OUD) in Ontario, Canada: a mixed-methods study
por: Russell, Cayley, et al.
Publicado: (2022)

Perceived barriers related to testing, management and treatment of HCV infection among physicians prescribing opioid agonist therapy: The C‐SCOPE Study
por: Litwin, Alain H., et al.
Publicado: (2019)

Efficacy and Safety of Switching to Dolutegravir With Boosted Darunavir in Virologically Suppressed Adults With HIV-1: A Randomized, Open-Label, Multicenter, Phase 3, Noninferiority Trial: The DUALIS Study
por: Spinner, Christoph D, et al.
Publicado: (2020)

Changing Pattern of Opioid Users Attending an Opioid Agonist Treatment Clinic in North India
por: Bhat, Fazle R., et al.
Publicado: (2022)

What is the benefit of inconsistent opioid agonist treatment in patients with prescription opioid use disorder?
por: Weiss, R., et al.
Publicado: (2023)

Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada
por: Russell, Cayley, et al.
Publicado: (2022)

Antibody Responses After Analytic Treatment Interruption in Human Immunodeficiency Virus-1-Infected Individuals on Early Initiated Antiretroviral Therapy
por: Stephenson, Kathryn E., et al.
Publicado: (2016)

The effect of opioid analgesics, benzodiazepines, gabapentinoids, and opioid agonist treatment on mortality risk among opioid-dependent people.
por: Bharat, Chrianna, et al.
Publicado: (2022)

Estimating the prevalence of alcohol-related disorders and treatment utilization in Bremen 2016/2017 through routine data linkage
por: Möckl, Justin, et al.
Publicado: (2023)

Changes in the alcohol-specific disease burden during the COVID-19 pandemic in Germany: interrupted time series analyses
por: Manthey, Jakob, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_obbfug67fai57hpe68nahakfo2